Saag MS - Search Results

1

Late presentation for human immunodeficiency virus care in the United States and Canada.

Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Calzavara LM, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Kushel M, Goedert JJ, McKaig RG, Van Rompaey SE, Zhang J, Moore RD. Althoff KN, et al. Among authors: saag ms. Clin Infect Dis. 2010 Jun 1;50(11):1512-20. doi: 10.1086/652650. Clin Infect Dis. 2010. PMID: 20415573 Free PMC article.

2

High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

Saag MS, Crain MJ, Decker WD, Campbell-Hill S, Robinson S, Brown WE, Leuther M, Whitley RJ, Hahn BH, Shaw GM. Saag MS, et al. J Infect Dis. 1991 Jul;164(1):72-80. doi: 10.1093/infdis/164.1.72. J Infect Dis. 1991. PMID: 1676046

3

Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.

Marschner IC, Collier AC, Coombs RW, D'Aquila RT, DeGruttola V, Fischl MA, Hammer SM, Hughes MD, Johnson VA, Katzenstein DA, Richman DD, Smeaton LM, Spector SA, Saag MS. Marschner IC, et al. Among authors: saag ms. J Infect Dis. 1998 Jan;177(1):40-7. doi: 10.1086/513823. J Infect Dis. 1998. PMID: 9419168 Clinical Trial.

4

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data.

Ioannidis JP, Collier AC, Cooper DA, Corey L, Fiddian AP, Gazzard BG, Griffiths PD, Contopoulos-Ioannidis DG, Lau J, Pavia AT, Saag MS, Spruance SL, Youle MS. Ioannidis JP, et al. Among authors: saag ms. J Infect Dis. 1998 Aug;178(2):349-59. doi: 10.1086/515621. J Infect Dis. 1998. PMID: 9697714

5

Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy.

O'Sullivan CE, Drew WL, McMullen DJ, Miner R, Lee JY, Kaslow RA, Lazar JG, Saag MS. O'Sullivan CE, et al. Among authors: saag ms. J Infect Dis. 1999 Sep;180(3):847-9. doi: 10.1086/314943. J Infect Dis. 1999. PMID: 10438377 Clinical Trial.

6

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.

Call SA, Saag MS, Westfall AO, Raper JL, Pham SV, Tolson JM, Hellmann NS, Cloud GA, Johnson VA. Call SA, et al. Among authors: saag ms. J Infect Dis. 2001 Feb 1;183(3):401-8. doi: 10.1086/318078. Epub 2000 Dec 29. J Infect Dis. 2001. PMID: 11133371

7

Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases.

Coghlan ME, Sommadossi JP, Jhala NC, Many WJ, Saag MS, Johnson VA. Coghlan ME, et al. Among authors: saag ms. Clin Infect Dis. 2001 Dec 1;33(11):1914-21. doi: 10.1086/323783. Epub 2001 Oct 24. Clin Infect Dis. 2001. PMID: 11692304

8

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

Kilby JM, Lalezari JP, Eron JJ, Carlson M, Cohen C, Arduino RC, Goodgame JC, Gallant JE, Volberding P, Murphy RL, Valentine F, Saag MS, Nelson EL, Sista PR, Dusek A. Kilby JM, et al. Among authors: saag ms. AIDS Res Hum Retroviruses. 2002 Jul 1;18(10):685-93. doi: 10.1089/088922202760072294. AIDS Res Hum Retroviruses. 2002. PMID: 12167274 Clinical Trial.

9

A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.

Fischl MA, Ribaudo HJ, Collier AC, Erice A, Giuliano M, Dehlinger M, Eron JJ Jr, Saag MS, Hammer SM, Vella S, Morse GD, Feinberg JE, Demeter LM, Eshleman SH; Adult AIDS Clinical Trials Group 388 Study Team. Fischl MA, et al. Among authors: saag ms. J Infect Dis. 2003 Sep 1;188(5):625-34. doi: 10.1086/377311. Epub 2003 Aug 15. J Infect Dis. 2003. PMID: 12934177 Clinical Trial.

10

Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.

Bedimo R, Chen RY, Accortt NA, Raper JL, Linn C, Allison JJ, Dubay J, Saag MS, Hoesley CJ. Bedimo R, et al. Among authors: saag ms. Clin Infect Dis. 2004 Nov 1;39(9):1380-4. doi: 10.1086/424883. Epub 2004 Oct 11. Clin Infect Dis. 2004. PMID: 15494916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page